Structuring financing for a new healthcare facility requires combining multiple capital sources — typically tax-exempt debt, equity, philanthropy, and operational reserves — aligned to the project’s risk profile, timeline, and long-term clinical strategy.
Why It Matters
Healthcare facility development is among the most capital-intensive investments a health system will undertake. A mid-sized ambulatory surgery center (ASC) — a freestanding outpatient surgical facility — can range from $8 million to $25 million depending on scope and market. A full-service hospital tower or medical office building (MOB) can exceed $400 million. Getting the capital structure wrong at the outset creates debt service obligations that constrain clinical operations for decades.
Health systems in competitive markets like Indianapolis, IN face additional pressure. Population growth, payer mix shifts, and the rapid migration of procedures to outpatient settings are compressing margins while simultaneously demanding new facility investment. Leaders who treat financing as an afterthought — rather than a strategic input — routinely encounter cost overruns, construction delays, and misaligned debt covenants that limit future flexibility.
How It Works
Most nonprofit health systems access capital through tax-exempt municipal bonds issued under Section 501(c)(3) of the Internal Revenue Code. These bonds typically carry lower interest rates than taxable alternatives — historically 50 to 150 basis points lower — which materially reduces total debt service over a 20- to 30-year term. The issuance process, including rating agency review and bond counsel engagement, generally takes 90 to 180 days and should be initiated well before a guaranteed maximum price (GMP) — the contractual construction cost ceiling — is established with the general contractor.
Beyond bond financing, health systems commonly layer in additional sources. Philanthropy accounts for 5% to 15% of project cost in mission-driven facilities. Federal programs such as the USDA Community Facilities loan program or HUD Section 242 mortgage insurance support rural or safety-net facilities. Joint venture (JV) structures with private real estate developers or physician groups are increasingly used for MOBs and ASCs, where the health system contributes land or tenant credit while the developer contributes equity and assumes construction risk. The financing mix should be defined during the planning phase — typically 18 to 36 months before the projected opening date — not during permitting.
Key Considerations
Debt capacity analysis must precede site selection and program design. Rating agencies and lenders evaluate debt-to-capitalization ratios, days cash on hand, and operating margins when sizing new debt. A health system with a debt-to-capitalization ratio above 45% may face covenant restrictions that limit new issuance. Understanding that ceiling before committing to a project scope prevents the costly scenario of redesigning a facility mid-development to reduce cost.
The authority having jurisdiction (AHJ) — the state or local regulatory body responsible for approving healthcare construction — introduces compliance costs that must be built into financial models. Certificate of Need (CON) states, where regulators must approve new capacity before construction, add 6 to 24 months to project timelines and introduce regulatory risk that lenders price into their terms. Health system CFOs should model multiple financing scenarios — including delayed opening, cost escalation of 5% to 15% above GMP, and lower-than-projected volume ramp-up — before final board approval. As outlined in our healthcare real estate advisory services, scenario modeling is a standard component of sound capital planning.
Sale-leaseback structures are another tool worth evaluating. A health system that owns its real estate can monetize existing assets — selling a facility to an investor and leasing it back — to generate capital for new development without issuing new debt. This approach preserves balance sheet capacity while funding growth, though it introduces long-term occupancy cost that must be weighed against clinical flexibility needs.
Actionable Takeaway
Before your board approves a new facility development, commission a capital structure analysis that stress-tests at least three financing scenarios against your current balance sheet metrics, projected payer mix, and market demand data. Engage your investment banker, bond counsel, and a healthcare real estate advisor simultaneously — not sequentially. Compressing that coordination window by even 60 days can preserve construction pricing locked before escalation cycles. Health systems that approach development through a disciplined, multi-source financing framework consistently achieve better risk-adjusted returns than those that default to single-source debt issuance. For health systems evaluating a new facility development, the advisory team at Bremner Healthcare Real Estate is available for consultation to help model the right capital structure for your specific market and balance sheet position.
The practical tip: run your debt capacity analysis against your audited financials from the prior two fiscal years — not projections — to establish the conservative floor your lenders and rating agencies will actually use. Learn more about how capital strategy intersects with facility planning at Bremner Healthcare Real Estate’s healthcare advisory practice.
Bremner Real Estate partners with health systems to align real estate strategy with clinical performance and capital efficiency.
Frequently Asked Questions
What is the typical timeline from project approval to opening for a new healthcare facility?
From initial board approval to facility opening, most healthcare facility developments take 36 to 60 months depending on project complexity, regulatory environment, and financing structure. CON states typically add 6 to 24 months to that timeline. Simple ASC or MOB developments in non-CON states can move faster, sometimes opening within 24 to 30 months of approval when site control is established early and financing is structured in parallel with design.
What is a guaranteed maximum price (GMP) and when should it be established?
A guaranteed maximum price, or GMP, is a contractual agreement with the general contractor that sets the maximum cost the health system will pay for construction, with any overruns absorbed by the contractor within defined conditions. It should be established after schematic design is complete — typically at 30% to 60% design development — because finalizing the GMP too early introduces significant contingency padding that increases project cost unnecessarily.
How do joint venture structures work in healthcare real estate development?
In a joint venture, two or more parties — commonly a health system and a private real estate developer or physician group — share ownership, risk, and return in a facility project. The health system typically contributes land, brand, or a long-term lease commitment, while the developer contributes equity and manages construction risk. JV structures are common for MOBs and ASCs and can allow health systems to develop facilities without fully funding them from their own balance sheet, though governance and exit provisions must be carefully negotiated upfront.
What financial ratios do rating agencies examine when a health system issues new bonds for facility development?
Rating agencies including Moody’s, S&P, and Fitch examine several core metrics: debt-to-capitalization ratio, operating margin, days cash on hand, and debt service coverage ratio. A debt service coverage ratio below 1.5x — meaning the health system generates less than $1.50 in operating cash for every $1.00 of debt service — typically signals elevated risk and can result in a rating downgrade or higher borrowing costs. Health systems should review these metrics against sector medians before committing to new debt issuance.
Can a health system use a sale-leaseback to fund new facility development without issuing new debt?
Yes, sale-leaseback transactions allow a health system to sell an existing owned facility to a real estate investor and simultaneously execute a long-term lease to continue operating in that space. The proceeds from the sale can then fund new development. This strategy preserves debt capacity and keeps new obligations off the balance sheet as lease expense rather than funded debt, though health systems should carefully model the long-term lease cost and ensure the lease terms provide adequate operational flexibility before executing the transaction.